Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8430)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2022 (publication date) through May 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [PMID: 35646264 DOI: 10.4254/wjh.v14.i4.682] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v14/i4/682.htm |
| Number | Citing Articles |
| 1 |
Jing Qian, Shun‐zhong Gu, Yong‐jin Yan. Determination of rivaroxaban in rat plasma by ultra‐high‐performance liquid chromatography–Q‐Orbitrap high‐resolution mass spectrometry and its application to a pharmacokinetic study. Biomedical Chromatography 2022; 36(12) doi: 10.1002/bmc.5491
|
| 2 |
Nicoletta Riva, Walter Ageno. How to manage splanchnic vein thrombosis in patients with liver disease. Hematology 2023; 2023(1): 281 doi: 10.1182/hematology.2023000481
|
| 3 |
Babu Lal Meena, Shiv Kumar Sarin. Management of Portal vein Thrombosis in Cirrhosis. Seminars in Liver Disease 2024; 44(04): 416 doi: 10.1055/s-0044-1791247
|
| 4 |
Aitor Odriozola, Ángela Puente, Antonio Cuadrado, Coral Rivas, Ángela Anton, Francisco José González, Raúl Pellón, Emilio Fábrega, Javier Crespo, José Ignacio Fortea. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. Journal of Clinical Medicine 2022; 11(21): 6435 doi: 10.3390/jcm11216435
|
| 5 |
Zhiqian Liu, Xiying Yang, Haitao Jiang, Rui Xie, Hong Wang. Advancements of direct oral anticoagulants in cirrhotic individuals with portal vein thrombosis. Clinics and Research in Hepatology and Gastroenterology 2025; 49(4): 102553 doi: 10.1016/j.clinre.2025.102553
|
| 6 |
Giovanni Monaco, Luca Bucherini, Bernardo Stefanini, Fabio Piscaglia, Francesco Giuseppe Foschi, Luca Ielasi. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art. World Journal of Gastroenterology 2023; 29(33): 4962-4974 doi: 10.3748/wjg.v29.i33.4962
Abstract(766) |
Core Tip(717) |
Full Article(HTML)(3625)
|
Full Article with Cover (PDF)-1212K(172)
|
Full Article (Word)-143K(43)
|
Audio-313K(7)
|
Peer-Review Report-236K(83)
|
Answering Reviewers-568K(75)
|
Full Article (PDF)-462K(373)
|
Full Article (XML)-258K(85)
|
Times Cited (8)
|
Total Visits (8462)
|
Open
|
| 7 |
A. V. Yagoda, P. V. Koroy, L. S. Baisaeva, T. R. Dudov. Portal Vein Thrombosis in Liver Cirrhosis. Part 2: Treatment, Primary and Secondary Prevention. The Russian Archives of Internal Medicine 2024; 14(4): 251 doi: 10.20514/2226-6704-2024-14-4-251-259
|
| 8 |
Giuseppe Miceli, Anna Maria Ciaccio, Antonino Tuttolomondo. Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide. Journal of Clinical Medicine 2025; 14(9): 2914 doi: 10.3390/jcm14092914
|
| 9 |
Xia Ren, Yuan Huang, LiPing Ying, JinBo Wang. Risk factors of venous thromboembolism for liver tumors: a systematic review and meta-analysis. HPB 2024; 26(1): 1 doi: 10.1016/j.hpb.2023.09.008
|